Caffeine and Postoperative Neurocognitive Recovery
咖啡因与术后神经认知恢复
基本信息
- 批准号:10674966
- 负责人:
- 金额:$ 52.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-02 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AcetylcholineAcuteAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAnesthesia proceduresAnestheticsAreaArousalAwarenessBlindedBrainCaffeineCaringCharacteristicsClinicalClinical TrialsCognitionCognitiveConsumptionDataDeliriumDementiaDiagnosticDistressDoseElderlyElectroencephalographyFailureFamilyFutureGoalsHealth ExpendituresHospitalizationHourImpaired cognitionIncidenceInterventionIntravenousLength of StayMeasuresMemoryNeurobiologyNeurocognitiveOperative Surgical ProceduresOutcomeParticipantPatientsPlacebo ControlPlacebosPostoperative PeriodProcessPublic HealthPurinergic P1 ReceptorsRandomizedRecoveryReportingResearchRiskRisk ReductionScalp structureSeveritiesSubgroupSurgical complicationSyndromeSystemTechniquesTestingTherapeuticTimeWakefulnessantagonistarmcognitive functioncognitive testingdensitydesigneffective interventioneffective therapyexperiencefallsflexibilityfunctional declineimprovedinsightmeetingsmild cognitive impairmentmortalityneuralneurocognitive disordernovelpharmacologicpostoperative deliriumpreventprimary outcomepublic health relevancerandomized placebo controlled trialrandomized, clinical trialsrecruitsecondary analysissecondary outcomesegregationwireless
项目摘要
TITLE: CAFFEINE AND POSTOPERATIVE NEUROCOGNITIVE RECOVERY
PROJECT SUMMARY
Delirium is a distressing clinical syndrome characterized by failure of basic cognitive functions that affects
approximately 20-50% of older surgical patients. Delirium during surgical recovery is associated with increased
mortality, increased healthcare expenditures, and future cognitive and functional decline. Moreover, there is
pathophysiologic overlap between delirium and Alzheimer’s Disease-Related Dementias; patients experiencing
delirium demonstrate increased risk of future dementia. Unfortunately, the underlying neurobiology of delirium
remains incompletely understood, and there are no biologically informed, effective therapies for preventing
postoperative delirium and related complications. Our preliminary data suggest that caffeine reduces delirium
in the postanesthesia care unit (PACU) after major surgery by shifting cortical dynamics towards neural
criticality. Criticality refers to a system state that is poised to dynamically fluctuate to meet demands. For
cognition, neural criticality is a potential mechanism by which functionally segregated areas of the brain can be
dynamically integrated over space and time to optimize cognition. In our preliminary trial, participants receiving
caffeine at the end of surgery demonstrated increased electroencephalographic (EEG) markers of criticality in
the PACU concurrent with delirium reduction. Nonetheless, the relationships among caffeine, neural criticality,
and postoperative neurocognitive recovery require additional, rigorous testing. Our long-term goal is to improve
neurobiological understanding of delirium and related neurocognitive disorders, such that effective therapies
can be developed. The objectives of this proposal are to (1) test an intervention for reducing early
postoperative delirium while (2) identifying dynamic brain changes that reflect cognitive vulnerability. The
central hypothesis is that caffeine will improve postoperative neurocognitive recovery in older adults. We will
test this hypothesis via a randomized, placebo-controlled, quadruple-blinded clinical trial. Aim 1 will determine
whether caffeine reduces the incidence of early postoperative delirium. Participants (n=250) will be randomized
to placebo, low-dose caffeine, or high-dose caffeine in a three-arm parallel design. A sequential randomization
design will also be used to test one vs. two days of caffeine therapy. Aim 2 will identify cortical dynamics
underlying early postoperative delirium. A wireless, high-density whole-scalp EEG system will enable the
analysis of neural criticality and the associations with caffeine and delirium. Lastly, Aim 3 will use the same
EEG system to test baseline neural criticality in trial participants meeting criteria for Mild Cognitive Impairment,
as deviations from criticality have been reported in patients with this condition as well as Alzheimer’s Disease.
Overall, the proposed research is significant because results may provide an effective, neurobiologically
informed intervention for reducing early postoperative delirium and related consequences. Additionally, results
will provide neurobiological insight into vulnerable cortical dynamics that portend delirium and, possibly,
subsequent neurocognitive disorders.
标题:咖啡因与术后神经认知恢复
项目摘要
谵妄是一种令人痛苦的临床综合征,其特征是基本认知功能的失败,
约20-50%的老年外科患者。手术恢复期间的谵妄与增加
死亡率、医疗保健支出增加以及未来认知和功能下降。此外,
谵妄和阿尔茨海默病相关痴呆之间的病理生理学重叠;
谵妄表现出未来痴呆的风险增加。不幸的是,精神错乱的神经生物学基础
仍然不完全了解,也没有生物学上的信息,有效的治疗方法来预防
术后谵妄及相关并发症。我们的初步数据表明咖啡因能减少谵妄
在麻醉后监护室(PACU)中,通过将皮质动力学向神经动力学转移,
临界性关键性是指系统状态准备动态波动以满足需求。为
神经临界性是一种潜在的机制,通过这种机制,大脑的功能分离区域可以被
在空间和时间上动态整合,以优化认知。在我们的初步试验中,
在手术结束时,咖啡因表现出增加的脑电图(EEG)标记的关键,
PACU同时伴有谵妄减少。尽管如此,咖啡因,神经临界状态,
和术后神经认知恢复需要额外的严格测试。我们的长期目标是改善
对谵妄和相关神经认知障碍的神经生物学理解,
可以开发。本提案的目标是:(1)测试干预措施,以减少早期
术后谵妄,同时(2)识别反映认知脆弱性的动态脑变化。的
中心假设是咖啡因将改善老年人术后神经认知恢复。我们将
通过随机、安慰剂对照、四盲临床试验来检验这一假设。目标1将决定
咖啡因是否能降低术后早期谵妄的发生率。将对受试者(n=250)进行随机分组
安慰剂,低剂量咖啡因,或高剂量咖啡因在一个三臂平行设计。顺序随机化
设计也将用于测试一天与两天的咖啡因治疗。目标2将识别皮质动力学
潜在的术后早期谵妄一个无线的,高密度的全头皮脑电图系统将使
分析神经临界状态以及咖啡因和谵妄的关系。最后,Aim 3将使用相同的
EEG系统用于测试符合轻度认知障碍标准的试验参与者的基线神经临界状态,
因为在患有这种疾病以及阿尔茨海默病的患者中已经报道了偏离临界状态。
总的来说,拟议的研究是重要的,因为结果可能提供一个有效的,神经生物学
减少术后早期谵妄和相关后果的知情干预。此外,结果
将提供神经生物学洞察脆弱的皮质动力学,预示着谵妄,可能,
神经认知障碍。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Caffeine, Postoperative Delirium And Change In Outcomes after Surgery (CAPACHINOS)-2: protocol for a randomised controlled trial.
- DOI:10.1136/bmjopen-2023-073945
- 发表时间:2023-05-15
- 期刊:
- 影响因子:2.9
- 作者:
- 通讯作者:
Barriers to delirium screening and management during hospital admission: a qualitative analysis of inpatient nursing perspectives.
- DOI:10.1186/s12913-023-09681-4
- 发表时间:2023-06-29
- 期刊:
- 影响因子:2.8
- 作者:Ragheb, Jacqueline;Norcott, Alexandra;Benn, Lakeshia;Shah, Nirav;McKinney, Amy;Min, Lillian;Vlisides, Phillip E.
- 通讯作者:Vlisides, Phillip E.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Phillip Eleas Vlisides其他文献
Phillip Eleas Vlisides的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Phillip Eleas Vlisides', 18)}}的其他基金
Caffeine and Postoperative Neurocognitive Recovery
咖啡因与术后神经认知恢复
- 批准号:
10517443 - 财政年份:2022
- 资助金额:
$ 52.36万 - 项目类别:
Neurocognitive Recovery following Surgery and General Anesthesia
手术和全身麻醉后的神经认知恢复
- 批准号:
10218208 - 财政年份:2018
- 资助金额:
$ 52.36万 - 项目类别:
Neurocognitive Recovery following Surgery and General Anesthesia
手术和全身麻醉后的神经认知恢复
- 批准号:
9979648 - 财政年份:2018
- 资助金额:
$ 52.36万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 52.36万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 52.36万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 52.36万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 52.36万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 52.36万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 52.36万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 52.36万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 52.36万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 52.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 52.36万 - 项目类别:
Operating Grants